There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
The 12th series of X Factor kicks off on ITV this Saturday but which previous winners went on to make it big?
A mother and her four young children who are feared to be travelling to Syria are being sought by police.
Hangovers cannot be prevented, even by drinking water or eating after boozing, scientists have concluded.